Induced Pluripotent Stem Cell Generation Using a Single Lentiviral Stem Cell Cassette

Cited by (677)

Items 301–400 of 677

1. Generation of rabbit pluripotent stem cell lines
   Zsuzsanna Táncos, Csilla Nemes, Zsuzsanna Polgár, Elen Gócza, Nathalie Daniel, Tom A. E. Stout, Pouneh Maraghechi, Melinda Katalin Pirity, Pierre Osteil, Yann Tapponnier et al. · 2012 · Theriogenology
2. Genome-wide mapping of miRNAs expressed in embryonic stem cells and pluripotent stem cells generated by different reprogramming strategies
   Botao Zhao, Dehua Yang, Jing Jiang, Jinsong Li, Chunsun Fan, Menggui Huang, Yi Fan, Yan Jin, Youxin Jin · 2014 · BMC Genomics
3. Generation of Induced Pluripotent Stem Cells from Somatic Cells
   Young-Doug Sohn, Ji Woong Han, Young‐sup Yoon · 2012 · Progress in molecular biology and translational science
4. Chick derived induced pluripotent stem cells by the poly‐cistronic transposon with enhanced transcriptional activity
   Masafumi Katayama, Takashi Hirayama, Tetsuya Tani, Katsuhiko Nishimori, Manabu Onuma, Tomokazu Fukuda · 2017 · Journal of Cellular Physiology
5. Human Induced Pluripotent Stem Cells Derived Under Feeder-Free Conditions Display Unique Cell Cycle and DNA Replication Gene Profiles
   Henry C.Y. Chung, Ruby C.Y. Lin, Grant J. Logan, Ian E. Alexander, Perminder Singh Sachdev, Kuldip Sidhu · 2011 · Stem Cells and Development
6. Development of a protein marker panel for characterization of human induced pluripotent stem cells (hiPSCs) using global quantitative proteome analysis
   Natalia S. Pripuzova, Melkamu Getie‐Kebtie, Christopher Grunseich, Colin L. Sweeney, Harry L. Malech, Michail A. Alterman · 2015 · Stem Cell Research
7. Application of Cord Blood and Cord Blood-Derived Induced Pluripotent Stem Cells for Cartilage Regeneration
   Yeri Alice Rim, Yoojun Nam, J. Ju · 2018 · Cell Transplantation
8. Redox and Epigenetics in Human Pluripotent Stem Cells Differentiation
   Sebastiano Giallongo, Daniela Řeháková, Marco Raffaele, Oriana Lo Re, Irena Koutná, Manlio Vinciguerra · 2020 · Antioxidants and Redox Signaling
9. A Hierarchy in Reprogramming Capacity in Different Tissue Microenvironments: What We Know and What We Need to Know
   Stefan Liebau, Pallavi U. Mahaddalkar, Hans Armin Kestler, Anett Illing, Thomas Theodor Werner Seufferlein, Alexander Kleger · 2012 · Stem Cells and Development
10. Mediator Subunit Med28 Is Essential for Mouse Peri-Implantation Development and Pluripotency
    Lin Li, Ryan M. Walsh, Vilas Wagh, Marianne F. James, Roberta L. Beauchamp, Yuh-Shin Chang, James F. Gusella, Konrad Hochedlinger, Vijaya Ramesh · 2015 · PLoS ONE
11. Reprogramming of Mouse, Rat, Pig, and Human Fibroblasts into iPS Cells
    Kuppusamy Rajarajan, Marc C. Engels, Sean M. Wu · 2012 · Current Protocols in Molecular Biology
12. Transcriptome Profiling Reveals Degree of Variability in Induced Pluripotent Stem Cell Lines: Impact for Human Disease Modeling
    Jens Schuster, Jonatan Halvardson, Laureanne Pilar E. Lorenzo, Adam Ameur, Maria Sobol, Doroteya Raykova, Göran Annerén, Lars Feuk, Niklas Dahl · 2015 · Cellular Reprogramming
13. Future alternative therapies for β-thalassemia
    Stefano Rivella, Eliezer A. Rachmilewitz · 2009 · Expert Review of Hematology
14. Diagnostic value and safety of long-term video-EEG monitoring.
    Andrew Che-Fai Hui, Patrick Kwan, Thomas Wai Hong Leung, Yannie O. Y. Soo, Vincent Mok, Ka Sing Wong · 2007 · PubMed
15. Rapid functional genetics of the oligodendrocyte lineage using pluripotent stem cells
    Angela M. Lager, Olivia Corradin, Jared M. Cregg, Matthew S. Elitt, H. Elizabeth Shick, Benjamin L.L. Clayton, Kevin Cameron Allan, Hannah E. Olsen, Mayur Madhavan, Paul J. Tesar · 2018 · Nature Communications
16. Renal stem cell reprogramming: Prospects in regenerative medicine
    Elvin E. Morales · 2014 · World Journal of Stem Cells
17. WDR5, BRCA1, and BARD1 Co-regulate the DNA Damage Response and Modulate the Mesenchymal-to-Epithelial Transition during Early Reprogramming
    Georgina Peñalosa-Ruiz, Vicky Bousgouni, Jan P. Gerlach, Susan Waarlo, Joris V. van de Ven, Tim Veenstra, José Silva, Simon J. van Heeringen, Chris Bakal, Klaas W. Mulder et al. · 2019 · Stem Cell Reports
18. Automated procedure for biomimetic de-cellularized lung scaffold supporting alveolar epithelial transdifferentiation
    Eric D. Girard, Todd Jensen, Stephanie Vadasz, Alex E. Blanchette, Fan Zhang, Camilo Moncada, Daniel J. Weiss, Christine M Finck · 2013 · Biomaterials
19. BCAR3/AND-34 can signal independent of complex formation with CAS family members or the presence of p130Cas
    Pierre Vanden Borre, Richard I. Near, Anthony Makkinje, Gustavo Mostoslavsky, Adam Lerner · 2011 · Cellular Signalling
20. Generation and genetic modification of induced pluripotent stem cells
    Axel Schambach, Tobias Cantz, Christopher Baum, Toni Cathomen · 2010 · Expert Opinion on Biological Therapy
21. Generation of iPS Cells Using a BacMam Multigene Expression System
    Yoko Takata, Hiroe Kishine, Takefumi Sone, Taichi Andoh, Masami Nozaki, Michael J. Poderycki, Jonathan D. Chesnut, Fumio Imamoto · 2011 · Cell Structure and Function
22. Induced Pluripotent Stem Cells—A New Foundation in Medicine
    G. T. Huang · 2010 · Journal of Experimental & Clinical Medicine
23. Can Pluripotent Stem Cells Be Used in Cell-Based Therapy?
    Virgínia Picanço‐Castro, Lílian Figueiredo Moreira, Simone Haddad Kashima, Dimas Tadeu Covas · 2014 · Cellular Reprogramming
24. A comprehensive analysis of induced pluripotent stem cell (iPSC) production and applications
    Margarita Matiukhova, Anastasia Ryapolova, Vladimir S. Andriianov, Vasiliy V. Reshetnikov, Sofia Zhuravleva, Roman A. Ivanov, Alexander V. Karabelsky, Ekaterina Minskaia · 2025 · Frontiers in Cell and Developmental Biology
25. Prime editing-mediated correction of the CFTR W1282X mutation in iPSCs and derived airway epithelial cells
    Chao Li, Zhong Liu, Justin D. Anderson, Zhongyu Liu, Liping Tang, Li Yao, Ning Peng, Jianguo Chen, Xueming Liu, Lianwu Fu et al. · 2023 · PLoS ONE
26. A Genetically Encoded Tool Kit for Manipulating and Monitoring Membrane Phosphatidylinositol 4,5-Bisphosphate in Intact Cells
    Fabian Hertel, Agathe Switalski, Elisa Mintert-Jancke, Katharina Karavassilidou, Kirsten Bender, Lutz Pott, Marie‐Cécile Kienitz · 2011 · PLoS ONE
27. Survival and Differentiation of Adenovirus-Generated Induced Pluripotent Stem Cells Transplanted into the Rat Striatum
    Kyle D. Fink, Julien Rossignol, Ming Lü, Xavier T. Lévêque, Travis D. Hulse, Andrew T. Crane, Véronique Nerrière‐Daguin, Robert D. Wyse, Phillip A. Starski, Matthew T. Schloop et al. · 2013 · Cell Transplantation
28. A library of ATTR amyloidosis patient-specific induced pluripotent stem cells for disease modelling and in vitro testing of novel therapeutics
    Richard M. Giadone, Jessica D. Rosarda, Prithvi Reddy Akepati, Arianne C. Thomas, Batbold Boldbaatar, Marianne F. James, Andrew A. Wilson, Vaishali Sanchorawala, Lawreen Heller Connors, John L. Berk et al. · 2018 · Amyloid
29. Potential therapeutic applications of differentiated induced pluripotent stem cells (iPSCs) in the treatment of neurodegenerative diseases
    Aijing Gao, Yuhua Peng, Yulin Deng, Hong Qing · 2012 · Neuroscience
30. Patient-Derived Induced Pluripotent Stem Cells and Organoids for Modeling Alpha Synuclein Propagation in Parkinson's Disease
    Yong Hui Koh, Li Yi Tan, Shi‐Yan Ng · 2018 · Frontiers in Cellular Neuroscience
31. B1 SINE-binding ZFP266 impedes mouse iPSC generation through suppression of chromatin opening mediated by reprogramming factors
    Daniel F. Kaemena, Masahito Yoshihara, Meryam Beniazza, James Ashmore, Suling Zhao, Mårten Bertenstam, Victor Olariu, Shintaro Katayama, Keisuke Okita, Simon R. Tomlinson et al. · 2023 · Nature Communications
32. Cell Surface Marker Mediated Purification of iPS Cell Intermediates from a Reprogrammable Mouse Model
    Christian Maximilian Nefzger, Sara Alaei, Anja S. Knaupp, Melissa L. Holmes, Jose Maria Polo · 2014 · Journal of Visualized Experiments
33. OVOL1 Influences the Determination and Expansion of iPSC Reprogramming Intermediates
    Harunobu Kagawa, Ren Shimamoto, Shin‐Il Kim, Fabian Oceguera-Yañez, Takuya Yamamoto, Timm Schroeder, Knut Woltjen · 2019 · Stem Cell Reports
34. Generation of Human Induced Pluripotent Stem Cells Using a Defined, Feeder‐Free Reprogramming System
    Seonmi Park, Gustavo Mostoslavsky · 2018 · Current Protocols in Stem Cell Biology
35. An ES-Like Pluripotent State in FGF-Dependent Murine iPS cells
    Bruno Di Stefano, Christa Buecker, Federica Ungaro, Alessandro Prigione, Hsu-Hsin Chen, Maaike Welling, Maureen Eijpe, Gustavo Mostoslavsky, Paul J. Tesar, James Adjaye et al. · 2010 · PLoS ONE
36. Generation of Human Induced Pluripotent Stem Cells from Extraembryonic Tissues of Fetuses Affected by Monogenic Diseases
    Paola Spitalieri, Rosa Valentina Talarico, Annalisa Botta, Michela Murdocca, Maria Rosaria D’Apice, Augusto Orlandi, Emiliano Giardina, Massimo Santoro, Francesco Brancati, Giuseppe Novelli et al. · 2015 · Cellular Reprogramming
37. Toward Tightly Tuned Gene Expression Following Lentiviral Vector Transduction
    Audrey Page, Floriane Fusil, François‐Loïc Cosset · 2020 · Viruses
38. Nox4 promotes endothelial differentiation through chromatin remodeling
    Fabian Hahner, Franziska Moll, Timothy Warwick, D.M. Hebchen, Giulia Buchmann, Jeremy Epah, Wesley Tyler Abplanalp, Tim Schader, Stefan Günther, Ralf Gilsbach et al. · 2022 · Redox Biology
39. Combining stem cell rejuvenation and senescence targeting to synergistically extend lifespan
    Prameet Kaur, Agimaa Otgonbaatar, Anupriya Ramamoorthy, Ellora Hui Zhen Chua, Nathan Harmston, Jan Gruber, Nicholas S. Tolwinski · 2022 · Aging
40. Cord blood for tissue regeneration
    Anja Buchheiser, Stefanie Liedtke, Leendert H. J. Looijenga, Gesine Kögler · 2009 · Journal of Cellular Biochemistry
41. A Chimeric Vitronectin: IGF-I Protein Supports Feeder-Cell-Free and Serum-Free Culture of Human Embryonic Stem Cells
    Kerry J. Manton, Sean Richards, Derek R. Van Lonkhuyzen, Luke Cormack, David Ian Leavesley, Zee Upton · 2010 · Stem Cells and Development · Retracted
42. Donor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells
    James A. Heslop, Richard Kia, Christopher S. Pridgeon, Rowena L. C. Sison-Young, Triantafillos Liloglou, Mohamed Elmasry, Stephen William Fenwick, JOHN S. MILLS, Neil R. Kitteringham, Christopher E. Goldring et al. · 2017 · Stem Cells Translational Medicine
43. BAK/BAX-Mediated Apoptosis Is a Myc-Induced Roadblock to Reprogramming
    Esther J.Y. Kim, Minna‐Liisa Änkö, Christoffer Flensberg, Ian J. Majewski, Fan‐Suo Geng, Jaber Firas, David C.S. Huang, Mark F. van Delft, Joan K. Heath · 2018 · Stem Cell Reports
44. Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells
    Flávia S. Donaires, Raquel M. Alves‐Paiva, Fernanda Gutierrez‐Rodrigues, Fernanda Borges da Silva, Maria Florencia Tellechea, Lílian Figueiredo Moreira, Bárbara A. Santana, Fabı́ola Traina, Cynthia E. Dunbar, Thomas Winkler et al. · 2019 · Stem Cell Research
45. Chromosome Transplantation: A Possible Approach to Treat Human X-linked Disorders
    Marianna Paulis, Lucia Susani, Alessandra Castelli, Teruhiko Suzuki, Takahiko Hara, Letizia Straniero, Stefano Duga, Dario Strina, Stefano Mantero, Elena Caldana et al. · 2020 · Molecular Therapy — Methods & Clinical Development
46. Regulatory Dynamics of Tet1 and Oct4 Resolve Stages of Global DNA Demethylation and Transcriptomic Changes in Reprogramming
    Michela Bartoccetti, Bernard K. van der Veer, Xinlong Luo, Rita Khoueiry, Pin-Yi She, Manmohan S. Bajaj, Jiayi Xu, Adrian Janiszewski, Bernard Thienpont, Vincent Pasque et al. · 2020 · Cell Reports
47. Can cell-cultured meat from stem cells pave the way for sustainable alternative protein?
    Octavio Bignardi da Silva Nunes, Tiago Willian Buranello, Fabiana de Andrade Farias, Jenyffer Mairely Rosero, Kaiana Recchia, Fabiana Fernandes Bressan · 2025 · Current Research in Food Science
48. Concise Review: The Magic Act of Generating Induced Pluripotent Stem Cells: Many Rabbits in the Hat
    Gustavo Mostoslavsky · 2011 · Stem Cells
49. Current status and future prospects of patient-derived induced pluripotent stem cells
    Zhiqiang Wang, Jing Zheng, Ruolang Pan, Ye Chen · 2021 · Human Cell
50. Dual Mode of Mitochondrial ROS Action during Reprogramming to Pluripotency
    Elena V. Skvortsova, Igor B. Nazarov, Alexey N. Tomilin, Sergey A. Sinenko · 2022 · International Journal of Molecular Sciences
51. Establishment of a reporter system to monitor silencing status in induced pluripotent stem cell lines
    Kenichiro Donai, Kengo Kuroda, Yijie Guo, Kyoung-Ha So, Hideko Sone, Masayuki Kobayashi, Katsuhiko Nishimori, Tomokazu Fukuda · 2013 · Analytical Biochemistry
52. Technological Progress in Generation of Induced Pluripotent Stem Cells for Clinical Applications
    Seung-Ick Oh, Chang Kyu Lee, Kyung Jin Cho, Kyung-Ok Lee, Ssang‐Goo Cho, Sunghoi Hong · 2012 · The Scientific World JOURNAL
53. Exclusive generation of rat spermatozoa in sterile mice utilizing blastocyst complementation with pluripotent stem cells
    Joel Zvick, Monika Tarnowska-Sengül, Adhideb Ghosh, Nicola Bundschuh, Pjeter Gjonlleshaj, Laura C. Hinte, Christine L. Trautmann, Falko Noé, Xhem Qabrati, Seraina A. Domenig et al. · 2022 · Stem Cell Reports
54. miR-128a Acts as a Regulator in Cardiac Development by Modulating Differentiation of Cardiac Progenitor Cell Populations
    Sarah C. Hoelscher, Theresia Stich, Anne Diehm, Harald Lahm, Martina Dreßen, Zhong Zhang, Irina Neb, Zouhair Aherrahrou, Jeanette Erdmann, Heribert Schunkert et al. · 2020 · International Journal of Molecular Sciences
55. A Susceptibility Locus on Chromosome 13 Profoundly Impacts the Stability of Genomic Imprinting in Mouse Pluripotent Stem Cells
    Emily Swanzey, Thomas F. McNamara, Effie Apostolou, Mamta Tahiliani, Matthias Stadtfeld · 2020 · Cell Reports
56. The Cell Biology of Stem Cells
    Eran Meshorer, Kathrin Plath · 2010 · Advances in experimental medicine and biology
57. Manipulating cell fate through reprogramming: approaches and applications.
    Masaki Yagi, Joy E. Horng, K. Hochedlinger · 2024 · Development
58. Revisiting Mitochondrial Function and Metabolism in Pluripotent Stem Cells: Where Do We Stand in Neurological Diseases?
    Carla Lopes, Ana Cristina Rego · 2016 · Molecular Neurobiology
59. Integrating Vectors for Gene Therapy and Clonal Tracking of Engineered Hematopoiesis
    Luca Biasco, Michael Rothe, Juliane Wilhelmine Schott, Axel Schambach · 2017 · Hematology/Oncology Clinics of North America
60. MicroRNA characterization in equine induced pluripotent stem cells
    Lucia Natalia Moro, Guadalupe Amín, Verónica Alejandra Furmento, Ariel Waisman, Ximena Garate, Gabriel Neiman, Alejandro La Greca, Natalia Lucía Santín Velazque, Carlos Luzzani, Gustavo Emilio Sevlever et al. · 2018 · PLoS ONE
61. Generation of neural progenitor cells from porcine‐induced pluripotent stem cells
    Lucas Simões Machado, Naira Caroline Godoy Pieri, Ramon César Botigelli, Raquel Vasconcelos Guimarães de Castro, Aline Fernanda de Souza, Alessandra Bridi, Marina Amaro de Lima, Paulo Fantinato Neto, Laís Vicari de Figueirêdo Pessôa, Simone Maria Massami Kitamura Martins et al. · 2020 · Journal of Tissue Engineering and Regenerative Medicine
62. BAF complex-mediated chromatin relaxation is required for establishment of X chromosome inactivation
    Andrew Keniry, Natasha Jansz, Linden J. Gearing, Iromi Wanigasuriya, Joseph Chen, Christian Maximilian Nefzger, Peter F. Hickey, Quentin A. Gouil, Joy J. Liu, Kelsey A. Breslin et al. · 2022 · Nature Communications
63. Reprogramming to a pluripotent state modifies mesenchymal stem cell resistance to oxidative stress
    Karina Dutra Asensi, Rodrigo S. Fortunato, Danúbia Silva dos Santos, Thaísa S. Pacheco, Danielle Ferreira de Rezende, Deivid C. Rodrigues, Fernanda Mesquita, Taís Hanae Kasai-Brunswick, Antônio Carlos Campos de Carvalho, Denise Pires de Carvalho et al. · 2014 · Journal of Cellular and Molecular Medicine
64. Modulation of chromatin modifying factors’ gene expression in embryonic and induced pluripotent stem cells
    Carlos Luzzani, Claudia Solari, Noelia Losino, Ariel Waisman, Leonardo Romorini, Carolina Blüguermann, Gustavo Emilio Sevlever, Lino Barañao, Santiago Miriuka, Alejandra Guberman · 2011 · Biochemical and Biophysical Research Communications
65. Nuclear reprogramming with a non-integrating human RNA virus
    Christopher B. Driscoll, Jason M. Tonne, Moustafa M. El Khatib, Roberto Cattaneo, Yasuhiro Ikeda, Patricia Devaux · 2015 · Stem Cell Research & Therapy
66. The Protein Coexpression Problem in Biotechnology and Biomedicine: Virus 2A and 2A-Like Sequences Provide a Solution
    Garry A. Luke, Martin D. Ryan · 2013 · Future Virology
67. ONSL and OSKM cocktails act synergistically in reprogramming human somatic cells into induced pluripotent stem cells.
    Laura Jung, P. Tropel, Y. Moal, Marius Teletin, E. Jeandidier, R. Gayon, Christian Himmelspach, Fiona Bello, Cécile André, Adeline Tosch et al. · 2014 · Molecular human reproduction
68. Maintenance and Neuronal Differentiation of Chicken Induced Pluripotent Stem-Like Cells
    Rui Dai, Ricardo Antonio Rosselló, Chun‐Chun Chen, Joeran Kessler, Ian G. Davison, Ute Hochgeschwender, Erich David Jarvis · 2014 · Stem Cells International
69. Trisomy 21 Mid-Trimester Amniotic Fluid Induced Pluripotent Stem Cells Maintain Genetic Signatures During Reprogramming: Implications for Disease Modeling and Cryobanking
    Caterina Pipino, Sayandip Mukherjee, Anna Louise David, Michael P. Blundell, Steven W. Shaw, Peggy Sung, Panicos Shangaris, Jonathan J. Waters, Drew Ellershaw, Marina Cavazzana et al. · 2014 · Cellular Reprogramming
70. Baicalin improves IVM of pig oocytes and subsequent preimplantation embryo development by inhibiting apoptosis
    Qing Guo, Mei‐Fu Xuan, Zhao‐Bo Luo, Junxia Wang, Song‐Shan Jin, Xi‐Jun Yin, Jin‐Dan Kang · 2019 · Reproduction Fertility and Development
71. Somatic Lineage Reprogramming
    Hannah Shelby, Tara Shelby, Marius Wernig · 2021 · Cold Spring Harbor Perspectives in Biology
72. Differentiation of Human Induced Pluripotent Stem Cells (hiPSCs) into Osteoclasts
    I‐Ping Chen · 2020 · BIO-PROTOCOL
73. Tryptophan Hydroxylase-2-Mediated Serotonin Biosynthesis Suppresses Cell Reprogramming into Pluripotent State
    Sergey A. Sinenko, Andrey A. Kuzmin, Elena V. Skvortsova, Sergey V. Ponomartsev, Evgeniya V. Efimova, Michael Bäder, Natalia V. Alenina, Alexey N. Tomilin · 2023 · International Journal of Molecular Sciences
74. Current Reprogramming Systems in Regenerative Medicine: From Somatic Cells to Induced Pluripotent Stem Cells
    Chenxia Hu, Lanjuan Li · 2015 · Regenerative Medicine
75. Development and Gene Expression of Porcine Cloned Embryos Derived from Bone Marrow Stem Cells with Overexpressing Oct4 and Sox2
    Jeong-Hyeon Lee, Won‐Jae Lee, Ryoung‐Hoon Jeon, Yeon-Mi Lee, Si‐Jung Jang, Sung‐Lim Lee, B. J. Jeon, Sun‐A Ock, W. Allan King, Gyu‐Jin Rho · 2014 · Cellular Reprogramming
76. Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic coculture
    Michael G. Daniel, David M Sachs, Jeffrey M. Bernitz, Yesai S. Fstkchyan, Katrina Rapp, Namita Satija, Kenneth Law, Foram Patel, Andreia M. Gomes, Huen‐Suk Kim et al. · 2019 · FEBS Letters
77. Pluripotency of Induced Pluripotent Stem Cells
    Chunjing Feng, Yundan Jia, Xiaoyang Zhao · 2013 · Genomics Proteomics & Bioinformatics
78. Manipulating and studying gene function in human pluripotent stem cell models
    Elisa Balmas, Federica Sozza, Sveva Bottini, Maria Luisa Ratto, Giulia Savoré, Silvia Becca, Kirsten E Snijders, Alessandro Bertero · 2023 · FEBS Letters
79. Generation of iPSCs from Genetically Corrected Brca2 Hypomorphic Cells: Implications in Cell Reprogramming and Stem Cell Therapy
    Susana Navarro, V. Moleiro, Francisco J. Molina-Estévez, M. Luz Lozano, Raquel Chinchon, Elena Almarza, Oscar Quintana Bustamante, Gustavo Mostoslavsky, Tobias Maetzig, Melanie Galla et al. · 2013 · Stem Cells
80. Fluorescent tagged episomals for stoichiometric induced pluripotent stem cell reprogramming
    Christopher E. Schmitt, Blanca M. Morales, Ellen M. H. Schmitz, John S. Hawkins, Carlos O. Lizama, Joan P. Zape, Edward Chiaming Hsiao, Ann C. Zovein · 2017 · Stem Cell Research & Therapy
81. Current standards and pitfalls associated with the transfection of primary fibroblast cells
    Mirosław Kucharski, Patrycja Mrowiec, Ewa Anna Oclon · 2021 · Biotechnology Progress
82. Induced pluripotent stem cells and hepatic differentiation
    Chih-Hung Chiang, Teh‐Ia Huo, Cho-Chin Sun, Jung-Hung Hsieh, Yueh Chien, Kai‐Hsi Lu, Shou‐Dong Lee · 2013 · Journal of the Chinese Medical Association
83. A virus-free vector for the transfection of somatic cells to obtain IPSC
    Hanife Sevgi Varlı, Funda Alkan, Murat Demirbilek, Nelisa Türkoğlu · 2019 · Journal of Nanoparticle Research
84. Metabolic control of induced pluripotency
    S. A. Sinenko, A. Tomilin · 2024 · Frontiers in Cell and Developmental Biology
85. From Hair to iPSCs—A Guide on How to Reprogram Keratinocytes and Why
    Stefanie Klingenstein, Moritz Klingenstein, Alexander Kleger, Stefan Liebau · 2020 · Current Protocols in Stem Cell Biology
86. The Use of Patient-Specific Induced Pluripotent Stem Cells (iPSCs) to Identify Osteoclast Defects in Rare Genetic Bone Disorders
    I‐Ping Chen · 2014 · Journal of Clinical Medicine
87. Transient expression of OCT4 is sufficient to allow human keratinocytes to change their differentiation pathway
    Doina M. Racila, Michael C. Winter, M Said, Ann Tomanek‐Chalkley, Susan C. Wiechert, Richard L. Eckert, Jackie R. Bickenbach · 2010 · Gene Therapy
88. Immortalized prairie vole-derived fibroblasts (VMF-K4DTs) can be transformed into pluripotent stem cells and provide a useful tool with which to determine optimal reprogramming conditions
    Masafumi KATAYAMA, Takashi Hirayama, Tohru Kiyono, Manabu Onuma, Tetsuya Tani, Satoru Takeda, Katsuhiko Nishimori, Tomokazu Fukuda · 2017 · Journal of Reproduction and Development
89. Induced Pluripotent Stem Cells: Hope in the Treatment of Diseases, including Muscular Dystrophies
    Daniela Gois Beghini, Samuel Iwao Maia Horita, Cynthia Machado Cascabulho, Luiz Anastácio Alves, Andrea Henriques‐Pons · 2020 · International Journal of Molecular Sciences
90. Cancer Risk Assessment and the Genetic Counseling Process: Using Hereditary Breast and Ovarian Cancer as an Example
    Sandra K. Prucka, Dawn E. McIlvried, Bruce R. Korf · 2008 · Medical Principles and Practice
91. Human Pluripotent Stem Cells and Derived Neuroprogenitors Display Differential Degrees of Susceptibility to BH3 Mimetics ABT-263, WEHI-539 and ABT-199
    Carolina Paola García, Guillermo A. Videla-Richardson, Nicolás Alexis Dimopoulos, Damián Darío Fernandez Espinosa, Santiago Miriuka, Gustavo Emilio Sevlever, Leonardo Romorini, María Élida Scassa · 2016 · PLoS ONE
92. CRISPR-Cas9 targeted deletion of the C9orf72 repeat expansion mutation corrects cellular phenotypes in patient-derived iPS cells
    Mochtar Pribadi, Zhongan Yang, Tanya S. Kim, Elliot W. Swartz, Alden Huang, Jason Chen, Deepika Reddy Dokuru, Jaeyun Baek, Fuying Gao, Andrea Fua et al. · 2016 · bioRxiv (Cold Spring Harbor Laboratory)
93. Cross-species higher sensitivities of FcγRIIIA/FcγRIV to afucosylated IgG for enhanced ADCC
    Changchuin Mao, Richard I. Near, Xuemei Zhong, Wenda Gao · 2021 · Antibody Therapeutics
94. Brief Report: Impaired Cell Reprogramming in Nonhomologous End Joining Deficient Cells
    Francisco J. Molina-Estévez, M. Luz Lozano, Susana Navarro, Yaima Torres, Ivana Grabundžija, Zoltán Ivics, Enrique Samper, Juan Antonio Bueren, Guillermo Güenechea · 2013 · Stem Cells
95. Temporal epigenetic modifications differentially regulate ES cell-like colony formation and maturation
    Jong Seop Rim, Karen L. Strickler, Christian W. Barnes, Lettie L. Harkins, Jarosław Staszkiewicz, Jeffrey M. Gimble, Gregory H. Leno, Kenneth J. Eilertsen · 2012 · Stem Cell Discovery
96. Transcriptional regulation of SPROUTY2 by MYB influences myeloid cell proliferation and stem cell properties by enhancing responsiveness to IL-3
    Mary L. Clarke, Giacomo Volpe, Lozan Sheriff, D Walton, Carl Ward, Wenbin Wei, Stéphanie Dumon, Paloma García, Jon Frampton · 2016 · Leukemia
97. A feeder- and xeno-free human induced pluripotent stem cell line obtained from primary human dermal fibroblasts with epigenetic repression of reprogramming factors expression: GPCCi001-A
    Michał Lach, Joanna Patrycja Wróblewska, Ewelina Augustyniak, Katarzyna Ida Kulcenty, Wiktoria Maria Suchorska · 2017 · Stem Cell Research
98. Novel Cell-Based and Tissue Engineering Approaches for Induction of Angiogenesis as an Alternative Therapy for Diabetic Retinopathy
    Elmira Jalilian, Kenneth B. Elkin, Su Ryon Shin · 2020 · International Journal of Molecular Sciences
99. Cattle In Vitro Induced Pluripotent Stem Cells Generated and Maintained in 5 or 20% Oxygen and Different Supplementation
    Brendon Willian Bessi, Ramon César Botigelli, Naira Caroline Godoy Pieri, Lucas Simões Machado, Jéssica Brunhara Cruz, Pamela de Moraes, Aline Fernanda de Souza, Kaiana Recchia, Gabriela Barbosa, Raquel Vasconcelos Guimarães de Castro et al. · 2021 · Cells
100. Reprogramming Adipose Tissue-Derived Mesenchymal Stem Cells into Pluripotent Stem Cells by a Mutant Adeno-Associated Viral Vector
     Mong‐Jen Chen, Yuanqing Lu, Takashi Hamazaki, Hsin-Yin Tsai, Kirsten E. Erger, Thomas J. Conlon, Ahmed Samir Elshikha, Hong Li, Arun Srivastava, Chunli Yao et al. · 2013 · Human Gene Therapy Methods